Cargando…
Which Way to Choose for the Treatment of Metastatic Prostate Cancer: A Case Report and Literature Review
BACKGROUND: Prostate cancer (PCa) is the second most common cancer among males in the world and the majority of patients will eventually progress to the metastatic phase. How to choose an effective way for the treatment of metastatic PCa, especially in the later stage of the disease is still confusi...
Autores principales: | Yang, Xiangwei, Jiang, Donggen, Li, Yamei, Zhang, Tianzhi, Xu, Duanya, Chen, Xianju, Pang, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107685/ https://www.ncbi.nlm.nih.gov/pubmed/33981608 http://dx.doi.org/10.3389/fonc.2021.659442 |
Ejemplares similares
-
Revealing Prognostic Value of Skeletal-Related Parameters in Metastatic Castration-Resistant Prostate Cancer on Overall Survival: A Systematic Review and Meta-Analysis of Randomized Controlled Trial
por: Tong, Tongyu, et al.
Publicado: (2020) -
Efficacy and safety of Androgen Deprivation Therapy (ADT) combined with modified docetaxel chemotherapy versus ADT combined with standard docetaxel chemotherapy in patients with metastatic castration-resistant prostate cancer: study protocol for a multicentre prospective randomized controlled trial
por: Yang, Xiangwei, et al.
Publicado: (2022) -
Beta-adrenergic receptor blockade in angiosarcoma: Which beta-blocker to choose?
por: Embaby, Alaa, et al.
Publicado: (2022) -
An Unusual Case of Metastatic Basal Cell Carcinoma of the Prostate: A Case Report and Literature Review
por: Dong, Shiqiang, et al.
Publicado: (2020) -
Systematic Chromatin Accessibility Analysis Based on Different Immunological Subtypes of Clear Cell Renal Cell Carcinoma
por: Zhang, Shiqiang, et al.
Publicado: (2021)